SCHEMBL7712895

SCHEMBL7712895

C[Si](C)(C)C#Cc1ccc2c(c1)C(=O)CCC2

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 5/20 0.49
MAOA P21397 7/20 0.43
MAOB P27338 7/20 0.43
CYP2A6 P11509 1/20 0.42
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
PRKCI P41743 1/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PBRM1 Q86U86 1/20 0.37
BRD4 O60885 1/20 0.36
BAZ2B Q9UIF8 1/20 0.35
HSD17B1 P14061 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085122 0.80 GRM5 (0.38) GRM5GABRA1GABRG2GABRB3GABRA5
SCHEMBL14979694 0.79 GRM5 (0.47) GRM5MAOAMAOBCYP2A6GABRA1
SCHEMBL7085730 0.78 GRM5 (0.62) GRM5GABRA1GABRG2GABRB3GABRA5
SCHEMBL8607160 0.76 MAOB (0.48) GRM5MAOAMAOBCYP2A6PRKCI
SCHEMBL29649358 0.76 MAOB (0.62) GRM5MAOAMAOBCYP2A6PRKCI
SCHEMBL4219924 0.76 MAOB (0.62) GRM5MAOAMAOBCYP2A6PRKCI
SCHEMBL6239982 0.75 RARB (0.39) GRM5GABRA1GABRG2GABRB3GABRA5
SCHEMBL6596693 0.75 GRM5 (0.52) GRM5MAOAMAOBGABRA1GABRG2
SCHEMBL6235870 0.74 VHL (0.51) GRM5GABRA1GABRG2GABRB3GABRA5
SCHEMBL7535201 0.74 GRM5 (0.47) GRM5MAOAMAOBCYP2A6PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369100-B1 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids ALLERGAN SALES, INC. 2002-04-09 US disclosed
US-6025388-A Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids ALLERGAN SALES, INC. (US) 2000-02-15 US disclosed
EP-0828490-A1 RAR-beta SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY Allergan (US) 1998-03-18 EP disclosed
WO-1996033716-A1 RARβ SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY ALLERGAN (US) 1996-10-31 WO disclosed